VivoSeq
Other

CBD

0

Pipeline Programs↗

3

Active Trials↗

0

Companies Involved↗

CBD is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

71/100

Attrition Rate

14/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

14

clinical trials

Completed5 · 36%
Unknown status4 · 29%
Recruiting3 · 21%
Terminated2 · 14%

Clinical Trials

Trial Activity

14 trials

CBD-Microglia PET Study
Recruiting·YYale University·Phase 1·NCT04398719·15 enrolled
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
Recruiting·UUniversity of California, Los Angeles·Phase 1·NCT06859710·30 enrolled
Modulation of THC Effects by CBD: a Dose-ranging Study
Recruiting·—·Phase 1/2·NCT06099379·100 enrolled
Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy Volunteers
Completed·—·Phase 1·NCT07186283·14 enrolled
A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population
Completed·NNew Age Ventures LLC·Phase 1·NCT04601207·32 enrolled
Investigation of the Pharmacokinetic Profile of CBD
Completed·—·Phase 1·NCT05269706·60 enrolled
Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam
Completed·National Institute on Drug Abuse (NIDA)·Phase 1·NCT03398083·42 enrolled
The Effects of CBD Isolate on Menstrual-Related Symptoms
Completed·CCanopy Growth Corporation·Phase 2·NCT05679830·33 enrolled
Effect of Topical CBD Cream for Degenerative Hallux Disorders
Terminated·RRush University Medical Center·Phase 2/3·NCT04103814·11 enrolled
Role of CBD in Improving Alexithymia
Terminated·UUniversity of California, San Diego·Phase 2·NCT05832281·5 enrolled
Methodology for Developing an Occlusal Appliance With CBD Active Carrier
Unknown status·MMedical University of Silesia·Phase 2/3·NCT04775030·40 enrolled
Comparative PK Study Of THC/CBD Formulations
Unknown status·CCapSoil·Phase 1·NCT06149988·14 enrolled
Effect of Hemp-CBD on Patients With CIPN
Unknown status·MMain Line Health·Phase 2·NCT04398446·56 enrolled
CBD Knee Scope Study
Unknown status·FFoundation for Orthopaedic Research and Education·Phase 1·NCT05934500·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)